| Molecular formula | C36H48N6O7 |
| Molecular weight | 676.8 g/mol |
| Registered trials | 0 |
| PubChem CID | 24998056 |
Regulatory Status
Hexapeptide-11 has no FDA-approved label and is not authorized for any medical use. It is classified as an unapproved research compound, meaning any use outside a controlled research setting is not supported by regulatory review.
What Hexapeptide-11 Is
Hexapeptide-11 is a synthetic peptide with the molecular formula C36H48N6O7 and a molecular weight of about 676.8 g/mol. Its structure, cataloged under PubChem CID 24998056, is built from a chain of amino acid residues linked by peptide bonds. No drug label, mechanism of action, or approved pharmacological classification exists for this compound in the data reviewed.
Trial Footprint
No clinical trials are currently registered for hexapeptide-11. This absence of trial data means there is no clinical evidence available to describe safety or effects in humans.
FAQ
No. Hexapeptide-11 has no FDA-approved label and no approved medical use. It is currently classified as an unapproved research compound.
It is a synthetic peptide with the molecular formula C36H48N6O7 and a molecular weight of roughly 676.8 g/mol. Its structure is registered in PubChem under CID 24998056.
No clinical trials are currently registered for this compound. This means there is no clinical trial data on its effects or safety in humans.
No adverse event data is available for hexapeptide-11 in the sources reviewed. Because it lacks an approved label or clinical trial history, its safety profile in humans has not been established.
It means the substance has not undergone the regulatory review required for medical use and is not sold or marketed as a drug. Any use is limited to research contexts rather than clinical or consumer application.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem
Updated 2026-08-04